An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Arrospide, Arantzazu ^a,b   Forné, Carles ^c   Rué, Montse ^b,c   Torà, Núria ^b,d   Mar, Javier ^a,b,e   Baré, Marisa ^b,d,f  

^a Gipuzkoa Health Research Unit Alto Deba Integrated Health Organization   (Spain)

^b Health Services Research Network in Chronic Diseases (REDISSEC)   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

^d Hospital Universitari Parc Tauli (Sabadell)   (Spain)

^e Alto Deba Integrated Health Organization   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Breast cancer; Breast density; Individual risk; Risk models; Screening

Indexed keywords

ADULT; AGE DISTRIBUTION; ANALYTIC METHOD; ARTICLE; BARLOW MODEL; BREAST CANCER; CALIBRATION; CANCER RISK; CANCER SCREENING; COMPARATIVE STUDY; FEMALE; GAIL AND CHEN MODEL; HARRELL C STATISTIC; HOSMER LEMESHOW C STATISTIC; HUMAN; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SPAIN; STATISTICAL MODEL; VALIDITY;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; REPRODUCIBILITY OF RESULTS; RISK; SPAIN;

EID: 84889813660     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-587     Document Type: Article

References (39)

1. El cancer en España.com Sociedad Española de Oncología Médica (SEOM). http://www.seom.org/es/prensa/el-cancer-en-espanyacom?format=pdf, El cancer en España.com.
2. Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from, to 2000: comparison of mortality results from the CISNET breast cancer base case analysis. J Natl Cancer Inst Monogr 1975, 2006(36):112-121.
3. Vilaprinyo E, Puig T, Rue M. Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain. PLoS One 2012, 7(1):e30157. 10.1371/journal.pone.0030157, 3260221, 22272292.
4. El-Bastawissi AY, White E, Mandelson MT, Taplin SH. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000, 11(10):955-963. 10.1023/A:1026514032085, 11142530.
5. Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, et al. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control 2006, 17(10):1281-1290. 10.1007/s10552-006-0071-1, 1705538, 17111260.
6. Feuer EJ. Modeling the Impact of Adjuvant Therapy and Screening Mammography on U.S. Breast Cancer Mortality Between 1975 and 2000: Introduction to the Problem. J Natl Cancer Inst Monogr 2000, 2006(36):2-6.
7. Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. The Wisconsin breast cancer epidemiology simulation model. J Natl Cancer Inst Monogr 2006, 36:37-47.
8. Lee SJ, Zelen M. A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr 2006, 36:79-86.
9. Schousboe JT, Kerlikowske K, Loh AJ, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med 2011, 155:10-20. 10.7326/0003-4819-155-1-201107050-00003, 3759993, 21727289.
10. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81(24):1879-1886. 10.1093/jnci/81.24.1879, 2593165.
11. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006, 98(17):1215-1226. 10.1093/jnci/djj332, 16954474.
12. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006, 98(17):1204-1214. 10.1093/jnci/djj331, 16954473.
13. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998, 62(1):145-158. 10.1086/301670, 1376797, 9443863.
14. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23(7):1111-1130. 10.1002/sim.1668, 15057881.
15. Baré M, Montes J, Florensa R, Sentís M, Donoso L. Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 2003, 12(6):487-494. 10.1097/00008469-200312000-00007, 14639126.
16. Baré M, Bonfill X, Andreu X. Relationship between the method of detection and prognostic factors for breast cancer in a community with a screening programme. J Med Screen 2006, 13(4):183-191.
17. American College of Radiology The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) 2003, Reston (VA): American College of Radiology, 3, American College of Radiology.
18. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999, 91(18):1541-1548. 10.1093/jnci/91.18.1541, 10491430.
19. Anderson SJ, Ahnn S, Duff K. NSABP Biostatistical Center Technical Report 1992, Pittsburgh (PA): Department of Biostatistics, University of Pittsburgh.
20. Vilaprinyo E, Gispert R, Martínez-Alonso M, Carles M, Pla R, Espinas JA, et al. Competing risks to breast cancer mortality in Catalonia. BMC Cancer 2008, 8:331. 10.1186/1471-2407-8-331, 2636833, 19014473.
21. Wolfram Research, Inc. Mathematica version 7 2008, USA: Wolfram Research, Wolfram Research, Inc.
22. Hosmer D, Lemeshow S. Applied logistic regression 2000, New York: Wiley.
23. Harrell F, Califf R, Pryor D, Lee K, Rosati R. Evaluating the yield of medical tests. JAMA 1982, 247(18):2543-2546. 10.1001/jama.1982.03320430047030, 7069920.
24. Harrell F, Lee K, Mark D. Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
25. StataCorp Stata Statistical Software: Release 11 2009, College Station, TX: StataCorp LP, StataCorp.
26. Decarli A, Calza S, Masala G, Specchia C, Palli D, Gail MH. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst 2006, 98(23):1686-1693. 10.1093/jnci/djj463, 17148770.
27. Pastor-Barriuso R, Ascunce N, Ederra M, Erdozáin N, Murillo A, Alés-Martínez JE, et al. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study. Breast Cancer Res Treat 2013, 138(1):249-259. 10.1007/s10549-013-2428-y, 3586062, 23378108.
28. Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, et al. Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat 2012, 132(1):347-353. 10.1007/s10549-011-1900-9, 3827770, 22147080.
29. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008, 148(5):337-347. 10.7326/0003-4819-148-5-200803040-00004, 2674327, 18316752.
30. Darabi H, Czene K, Zhao W, Liu J, Hall P, Humphreys K. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res 2012, 14(1):R25. 10.1186/bcr3110, 3496143, 22314178.
31. Pastor Climente I, Morales Suarez-Varela M, Llopis González A, Magraner Gil JF. Application of the Gail method of calculating risk in the population of Valencia. Clin Transl Oncol 2005, 7(8):336-343. 10.1007/BF02716549, 16185602.
32. National Cancer Institute Breast Cancer Risk Assessment Tool, SAS codes for Gail model prediction http:www.cancer.govbcrisktool., National Cancer Institute.
33. Buron A, Vernet M, Roman M, Checa MA, Pérez JM, Sala M, et al. Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort. Breast Cancer Res 2013, 22(1):83-88.
34. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13(6):223. 10.1186/bcr2942, 3326547, 22114898.
35. Chiu SY-H, Duffy S, Yen AM-F, Tabár L, Smith RA, Chen H-H. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 2010, 19(5):1219-1228. 10.1158/1055-9965.EPI-09-1028, 20406961.
36. Garrido-Estepa M, Ruiz-Perales F, Miranda J, Ascunze N, González-Roman I, Sánchez-Contador C, et al. Evaluation of mammographic density patterns: reproducibility and concordance among scales. BMC Cancer 2010, 10:485. 2946309, 20836850.
37. Martin KE, Helvie MA, Zhou C, Roubidoux MA, Bailey JE, Paramagul C, et al. Mammographic density measured with quantitative computer-aided method: comparison with radiologists' estimates and BI-RADS categories. Radiology 2006, 240:656-665. 10.1148/radiol.2402041947, 16857974.
38. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DSM, Vacek PM, Smith-Bindman R, et al. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst 2007, 99(5):386-395. 10.1093/jnci/djk066, 17341730.
39. Pérez Lacasta M, Gregori A, Carles M, Gispert R, Martinez-Alonso M, Vilaprinyo E, et al. The evolution of breast cancer mortality and the dissemination of mammography in Catalonia: an analysis by health region. Rev Esp Salud Publica 2010, 84(6):691-703. 10.1590/S1135-57272010000600002, 21327306.